CNSP - CNS Pharmaceuticals, Inc.
2.94
-0.060 -2.041%
Share volume: 22,735
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$3.00
-0.06
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 3.545 M | 2.528 M | 5.629 M | 4.338 M | 2.409 M | 3.253 M | |
| Selling general and admin | 1.114 M | 1.412 M | 1.384 M | 1.095 M | 1.242 M | 1.057 M | |
| Research and development | 2.430 M | 1.117 M | 4.245 M | 3.243 M | 1.167 M | 2.197 M | |
| Total expenses | 3.545 M | 2.528 M | 5.629 M | 4.338 M | 2.409 M | 3.253 M | |
| -28.68% | 122.65% | -22.94% | -44.45% | 35.03% | |||
| Operating income | -3.545 M | -2.528 M | -5.629 M | -4.338 M | -2.409 M | -3.253 M | |
| Ebit | -3.545 M | -2.526 M | -5.604 M | -4.295 M | -2.371 M | -3.216 M | |
| Pretax income | -3.545 M | -2.531 M | -5.606 M | -4.301 M | -2.375 M | -3.218 M | |
| -28.61% | 121.51% | -23.27% | -44.79% | 35.52% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.545 M | -2.531 M | -5.606 M | -4.301 M | -2.375 M | -3.218 M | |
| 28.61% | -121.51% | 23.27% | 44.79% | -35.52% |